| Patents for C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms (7,144) |
|---|
| 10/19/2006 | WO2006109817A1 1,4-substituted piperazine derivative |
| 10/19/2006 | CA2603701A1 1,4-substituted piperazine derivative |
| 10/18/2006 | CN1847233A Method for preparing 4-formoxylbenzofuran |
| 10/17/2006 | US7122580 management, treatment and/or control of diseases caused in intrinsic clotting pathway utilizing factor IX such as stroke, myocardial infarction, aneurysm surgery, and deep vein thrombosis associated with surgical procedures etc |
| 10/17/2006 | US7122565 Thiadiazoles and oxadiazoles and their use as phosphodiesterase-7 inhibitors |
| 10/17/2006 | CA2226669C Herbicidal sulphonylamino(thio)carbonyl compounds |
| 10/12/2006 | WO2006031348A3 Mitotic kinesin inhibitors |
| 10/10/2006 | US7119112 Sulfonamides as potassium channel blockers |
| 10/05/2006 | WO2006105127A2 Hydroxysteroid dehydrogenase inhibitors |
| 10/05/2006 | WO2006078576A3 Aminomethyl beta-secretase inhibitors for the treatment of alzheimer's disease |
| 10/05/2006 | WO2006059245A3 Compounds for the treatment of cns and amyloid associated diseases |
| 10/05/2006 | CA2585333A1 Heterocyclical chromophore architectures with novel electronic acceptor systems |
| 10/04/2006 | EP1706396A1 N-(4-carbamimidoyl-benzyl)-2-alkoxy-2-heterocyclyl acetamides as inhibitors of the formation of coagulation factors xa, ixa and thrombin induced by factor viia |
| 10/04/2006 | EP1706392A2 Pesticidal heterocyclic dihaloallyl compounds |
| 10/04/2006 | EP1706372A1 Alpha-hydroxy amides as bradykinin antagonists or inverse agonists |
| 10/04/2006 | CN1840525A Organic electroluminescent material and its application |
| 10/03/2006 | US7115750 Melanin concentrating hormone antagonist |
| 10/03/2006 | US7115639 useful in the treatment and/or prevention of preterm labor, premature birth and dysmenorrhea; in particular, the present invention is related to pyrrolidine derivatives displaying a substantial modulatory, notably an antagonist activity of the oxytocin receptor |
| 10/03/2006 | US7115636 use as antiviral agents; treatment of cytomegalovirus infection |
| 10/03/2006 | US7115612 Arylsulfonamides as antiviral agents |
| 10/03/2006 | CA2234518C Process for preparing substituted oxadiazolones |
| 09/28/2006 | WO2006102645A1 Biaryl derived amide modulators of vanilloid vr1 receptor |
| 09/28/2006 | WO2006100502A1 11-beta-hydroxysteroid dehydrogenase inhibitors |
| 09/28/2006 | WO2005040157A3 Novel mch receptor antagonists |
| 09/28/2006 | US20060217433 Sulfonamide derivatives as ppar modulators |
| 09/28/2006 | CA2602583A1 Biaryl derived amide modulators of vanilloid vr1 receptor |
| 09/28/2006 | CA2598589A1 11-beta-hydroxysteroid dehydrogenase inhibitors |
| 09/27/2006 | EP1705179A1 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 09/27/2006 | EP1705174A1 Selective androgen receptor modulators and methods of use thereof |
| 09/27/2006 | EP1704143A1 Malononitrile compound as pesticides |
| 09/21/2006 | WO2006098489A1 Compound, composition, retardation plate, elliptically-polarizing plate and liquid-crystal display device |
| 09/21/2006 | WO2006067587A3 Nonnucleoside inhibitors of hiv-1 reverse transcriptase |
| 09/21/2006 | US20060211697 2-(2 Or 4-substituted aryloxy)-phenol derivatives as antibacterial agents |
| 09/21/2006 | US20060210533 Compounds and compositions for delivering active agents |
| 09/20/2006 | EP1549624A4 Inhibitors of fatty acid amide hydrolase |
| 09/20/2006 | CN1275917C Glucocorticoid receptor modulators |
| 09/19/2006 | US7109364 Compounds containing a specific branched chain end terminal group, which is isopropyl, sec.-butyl, or tert.-butyl; a polar leading group, and long chain aliphatic, non-cyclic, saturated or nonsaturated linking groups |
| 09/13/2006 | EP1699455A1 Heterocyclic aspartyl protease inhibitors |
| 09/13/2006 | EP0917462B1 Cell adhesion inhibitors |
| 09/13/2006 | CN1832944A Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide |
| 09/13/2006 | CN1832930A Amide derivative |
| 09/12/2006 | US7105538 4-oxo-4-[2-(5-pyridin-4-yl-[1,3,4]oxadiazol-2-yl)-pyrrolidin-1-yl]-butyric acid ethyl ester; inhibition of serotonin re-uptake; analgesic effect |
| 09/07/2006 | US20060199826 Cyclopropane compounds and pharmaceutical use thereof |
| 09/06/2006 | EP1698620A1 Benzene compounds disubstituted with cyclic groups at the 1- and 2-positions |
| 09/06/2006 | EP1697355A2 Amidino compounds as cysteine protease inhibitors |
| 09/06/2006 | EP1697333A1 (3,4-disubstituted)propanoic carboxylates as s1p (edg) receptor agonists |
| 09/06/2006 | CN1829714A Pna单体和前体 Pna monomers and precursors |
| 09/06/2006 | CN1829513A 5-membered heterocycle-based p-38 inhibitors |
| 09/05/2006 | USRE39263 2-2-fluoro-5-ethylsulphonylamino-4-thiocarbamoyl-phenyl)-5,6,7,8-tetrahydro-1,2,4triazolo[4,3-a]pyridin-3(2H)-one; post or preemergent |
| 09/05/2006 | US7102013 Treating under hydrolyzing conditions a hydantoin compound to form an alpha-amino acid derivative |
| 08/31/2006 | US20060194817 N-{(1S,2R)-1-(3,5-difluorobonzyl)-2-hydroxy-3-[(3-iodobonzyl)amino]propyl}-2-{4-[(methylsulfonyl)amino]phenyl}acetamide; inhibitors of the beta- secretase enzyme useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mamma |
| 08/30/2006 | EP1694638A1 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof |
| 08/30/2006 | EP1694410A2 Cyclopropane compounds and pharmaceutical use thereof |
| 08/30/2006 | CN1824657A 3-substituted-2-aryl substituted-5-(3,4,5-tri alkoxy phenyl)-1,-3,4-oxidazole derivative, its preparation method and use |
| 08/24/2006 | WO2006066126A3 Phenol-heterocyclic ligands, metal complexes, and their uses as catalysts |
| 08/24/2006 | US20060189810 Novel sulfonamide inhibitors of aspartyl protease |
| 08/24/2006 | US20060189657 Difluoroalkyl-subsituted amides such as morpholine-4-carboxylic acid {(S)-1-[(S)-1-(3-cyclopropyl-1,2,4-oxadiazole-5-carbonyl)-propylcarbamoyl]-3,3-difluoro-butyl}-amide; diseases associated wtih cathepsin S, K, and B such as neurodegenerative diseases, osteoporosis, emphysema, viral infection, cancer |
| 08/23/2006 | EP1692090A1 Conversion of amine- to carboxyl groups on solid surfaces |
| 08/23/2006 | EP0837052B1 Bicyclic amino derivatives and pgd 2 antagonist containing the same |
| 08/23/2006 | CN1821243A Substituted pyridine M receptor excitomotor, its preparing process and its use |
| 08/22/2006 | US7094902 Electroactive polymers |
| 08/22/2006 | US7094807 Viricides; hepatitis virus |
| 08/17/2006 | WO2006085112A1 Anthranilic acid derivatives as hm74a receptor agonists |
| 08/17/2006 | WO2006085108A1 Awthranilic acid derivatives and their use in treatment of diseases of lipid metabolism, in particular dyslipidaemia |
| 08/17/2006 | WO2005107762A3 Certain chemical entities, compositions, and methods |
| 08/17/2006 | US20060183903 Reacting 4-(alpha-(p-chlorophenyl)benzyl)-1-leaving group-alkylpiperazine with protected 1-hydroxy-1-(4-(p-hydroxyphenyl)-3-butynyl)urea to form 1-(4-(p-(4-(alpha-(p-chlorophenyl)benzyl)-1-piperazin-1-ylalkyl)phenyl)-3-butynyl)-1-hydroxyurea; preparation of intermediates |
| 08/16/2006 | CN1820006A Substituted oxyarenes, and use thereof for controlling pests |
| 08/16/2006 | CN1817870A Organic conjugated ligand, complex and use thereof |
| 08/16/2006 | CN1269811C Piperazine derivatives having SST1 antagonistic activity |
| 08/15/2006 | US7091380 Bradykinin B1 antagonists or inverse agonists, for prophylaxis and therapy of pain and inflammation |
| 08/15/2006 | US7090929 Metallic complexes covalently bound to conjugated polymers and electronic devices containing such compositions |
| 08/10/2006 | WO2006083271A2 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 08/10/2006 | US20060178411 Sulfonimide containing compounds and their use in polymer electrolyte membranes for electrochemical cells |
| 08/10/2006 | US20060177717 membrane electrodes; electrocatalysts; fuel cells |
| 08/10/2006 | CA2566809A1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 08/09/2006 | EP1687284A2 p-38 KINASE INHIBITORS |
| 08/08/2006 | US7087644 Cardiovascular disorders; stimulant of guanylate cyclase ; therapy for liver fibrosis |
| 08/08/2006 | US7087623 Thiazole and other heterocyclic ligands for mammalian dopamine, muscarinic and serotonin receptors and transporters, and methods of use thereof |
| 08/03/2006 | US20060173058 Kcnq channel modulating compounds and their pharmaceutical use |
| 08/03/2006 | US20060171881 Compounds with high monoamine transporter affinity |
| 08/02/2006 | CN1812966A N-alkynyl-2- (substituted aryloxy) alkylthioamide derivatives as fungicides |
| 08/01/2006 | US7084279 2,5-(alkylcarboxylic acid and aryl)-substituted 1,3,4-oxadiazole compounds, used for drug delivery |
| 08/01/2006 | US7083656 safe from toxicological and dermatological points of view and make it possible to achieve dyeings of the desired intensity; have a good light fastness, acid fastness, crocking resistance and good stability when washed. |
| 08/01/2006 | CA2189456C Substituted aromatic thiocarboxylic acid amides and their use as herbicides |
| 07/27/2006 | WO2006078995A1 Cardiovascular compounds comprising heterocyclic nitric oxide donor group compositions and methods of use |
| 07/27/2006 | WO2006078754A1 Novel quinolinium salts and derivatives |
| 07/27/2006 | WO2006078577A1 Tertiary carbinamines having substituted heterocycles, which are active as inhibitors of beta-secretase, for the treatment of alzheimer's disease |
| 07/27/2006 | WO2006034315A3 Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes |
| 07/27/2006 | US20060167063 Process for the manufacture of isradipine |
| 07/27/2006 | US20060167053 e.g. 3-(6-ethanesulfonylpyridin-3-yloxy)-5-(2-hydroxy-1-methyl-ethoxy)-N-(1-methyl-1H-pyrazol-3-yl)benzamide; glucokinase activator; antidiabetic agent; obesity, insulin resistance |
| 07/27/2006 | US20060166033 Polymerizable, luminescent compounds and mixtures, luminescent polymer materials and their use |
| 07/27/2006 | CA2595579A1 Cardiovascular compounds comprising heterocyclic nitric oxide donor group compositions and methods of use |
| 07/27/2006 | CA2595224A1 Novel quinolinium salts and derivatives |
| 07/27/2006 | CA2594946A1 Tertiary carbinamines having substituted heterocycles, which are active as inhibitors of beta-secretase, for the treatment of alzheimer's disease |
| 07/27/2006 | CA2594943A1 Aminomethyl beta-secretase inhibitors for the treatment of alzheimer's disease |
| 07/26/2006 | EP1682524A1 Novel keto-oxadiazole derivatives as cathepsin inhibitors |
| 07/26/2006 | CN1266118C Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides |
| 07/20/2006 | WO2006074796A1 Phenylbenzoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof |
| 07/20/2006 | CA2594384A1 Phenylbenzoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof |
| 07/19/2006 | EP1680107A1 Substituted oxadiazolidinediones als pai-1 inhibitors |